4C Biomed
Unlocking the Promise of Immune Checkpoint Inhibitors
Active
Seed
Startup
Netanya
Founded 2016-02
4C Biomed combines cutting-edge science, real-world clinical insights and unique autologous cell systems (i.e. cancer and immune cells from the same patient) to drive the development of immuno-oncology therapies. Its lead drug is in a stage of IND-enabling studies and is planned to enter clinical Phase I in 2025. 4C Biomed’s technology leverages a uniquely…
SectorHealth Tech & Life Sciences
StageSeed
Employees10
Founded2016-02
HQNetanya
Patents1
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals